Loading…
Reported covered position: Exec.Dir.Presidential Advisory Council HIV/AIDS
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
U.S.-Israel Security Cooperation Act
Client: GILEAD SCIENCES INC · Firm: GILEAD SCIENCES, INC.
Appropriations; education related to Hepatitis C treatment guidelines and funding issues (FY2016 Omnibus Appropriations bill.) Issues related to coverage, access and reimbursement of pharmaceuticals for veterans. Education related to Implementation of Veterans Access to Care Act, HR 4810/3230 and PL 113-146.
U.S.-Israel Security Cooperation Act
Client: GILEAD SCIENCES INC · Firm: GILEAD SCIENCES, INC.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
GILEAD SCIENCES INC via GILEAD SCIENCES, INC.
2017 · first_quarter · Q1
Pending healthcare legislation and potential impact on the biopharmaceutical industry; Ryan White Care Act reauthorization; Hepatitis C (HCV) policy; PEPFAR reauthorization; HIV/AIDS research, testing and treatment; Affordable Care Act implementation; HCV screening and linkage to care programs; coverage and reimbursement policy for HCV and HIV portfolio; funding for HCV and public health activities via appropriations. Pharmaceutical policy as it relates to payments under the 340B program; implementation of section 340B drug discount program. Prison population and hepatitis C.
Ryan White Care Act reauthorization; Hepatitis C (HCV) policy; HIV/AIDS research, testing and treatment; Affordable Care Act implementation; HCV screening and linkage to care programs. Federal program coverage, access and reimbursement issues for Hepatitis C, HIV, and oncology products. Coverage of pharmaceuticals, cost-sharing and other access issues; issues related to coverage and reimbursement of pharmaceuticals; FDA issues and 340B.
Source: Senate LDA
Appropriations; education related to Hepatitis C treatment guidelines and funding issues (FY2016 Omnibus Appropriations bill.) Issues related to coverage, access and reimbursement of pharmaceuticals for veterans. Education related to Implementation of Veterans Access to Care Act, HR 4810/3230 and PL 113-146. Health care for judiciary involved veterans.
Pending healthcare legislation and potential impact on the biopharmaceutical industry; Ryan White Care Act reauthorization; Hepatitis C policy; PEPFAR reauthorization; HIV/AIDS research, testing, and treatment; Affordable Care Act implementation; HCV screening and linkage to care programs; H.R. 6 - 21st Century Cures Act. Funding for HCV and public health activities via appropriations. Pharmaceutical policy as it relates to payments under the 340B program; implementation of section 340B drug discount program. S. 3056 - CREATES Act of 2016; S.524 - Comprehensive Addiction and Recovery Act of 2016 - HCV testing provision in bill; S.1287 - Viral Hepatitis Testing Act of 2015. Prison population and hepatitis C.The FOCUS program.
Coverage of pharmaceuticals, cost-sharing and other access issues; H.R. 6 - 21st Century Cures Act; Implementation of Public Law No: 111-148, the Patient Protection and Affordable Care Act; issues related to coverage and reimbursement of pharmaceuticals; issues related to Medicare, Medicaid, and Affordable Care Act implementation; FDA issues and 340B. S. 3056 - CREATES Act of 2016.
Ryan White Care Act reauthorization; Hepatitis C (HCV) policy; PEPFAR reauthorization; HIV/AIDS research, testing, and treatment; Affordable Care Act implementation; HCV testing, screening and linkage to care programs; H.R. 6 - 21st Century Cures Act. Federal program coverage; access and reimbursement issues for Hepatitis C, HIV, and oncology products. Coverage of pharmaceuticals, cost-sharing and other access issues; Implementation of Public Law No: 111-148; issues related to coverage and reimbursement of pharmaceuticals; FDA issues and 340B.
HIV/AIDS testing and treatment, technology transfer and patent rights and funding, patent reform legislation. Patient Protection and Affordable Care Act implementation. Issues related to access to pharmaceuticals and intellectual property protection. Intellectual property reform. S.1137 - PATENT Act & HR. 9 - Innovation Act.
HIV/AIDS testing and treatment, technology transfer and patent rights and funding, patent reform legislation. Patient Protection and Affordable Care Act implementation. Issues related to access to pharmaceuticals and intellectual property protection. Intellectual property reform. S.1137 - PATENT Act & HR. 9 - Innovation Act
HIV/AIDS testing and treatment, technology transfer and patent rights and funding, patent reform legislation. Patient Protection and Affordable Care Act implementation. Issues related to access to pharmaceuticals and intellectual property protection. Intellectual property reform. S.1137 - PATENT Act & HR. 9 - Innovation Act.
HIV/AIDS testing and treatment, technology transfer and patent rights and funding, patent reform legislation. Patient Protection and Affordable Care Act implementation. Issues related to access to pharmaceuticals and intellectual property protection. Intellectual property reform. S.1137 - PATENT Act & HR. 9 - Innovation Act.
HIV/AIDS testing and treatment, technology transfer and patent rights and funding, patent reform legislation. Patient Protection and Affordable Care Act implementation. Issues related to access to pharmaceuticals and intellectual property protection. Intellectual property reform. S.1137 - PATENT Act & HR. 9 - Innovation Act.
HIV/AIDS testing and treatment, technology transfer and patent rights and funding, patent reform legislation. Patient Protection and Affordable Care Act implementation. Issues related to access to pharmaceuticals and intellectual property protection. Intellectual property reform. S.1137 - PATENT Act & HR. 9 - Innovation Act
HIV/AIDS testing and treatment, technology transfer and patent rights and funding, patent reform legislation. Patient Protection and Affordable Care Act implementation. Issues related to access to pharmaceuticals and intellectual property protection. Intellectual property reform. S.1137 - PATENT Act & HR. 9 - Innovation Act.
HIV/AIDS testing and treatment, technology transfer and patent rights and funding, patent reform legislation. Patient Protection and Affordable Care Act implementation. Issues related to access to pharmaceuticals and intellectual property protection. Intellectual property reform. S.1137 - PATENT Act & HR. 9 - Innovation Act.
Pending healthcare legislation and potential impact on the biopharmaceutical industry; Ryan White Care Act reauthorization; Hepatitis C policy; PEPFAR reauthorization; HIV/AIDS research, testing, and treatment; Affordable Care Act implementation; HCV screening and linkage to care programs; House Committee on Energy and Commerce 21st Century Cures initiative. Funding for HCV and public health activities via appropriations. Pharmaceutical policy as it relates to payments under the 340B program; implementation of section 340B drug discount program. S. 3056 - CREATES Act of 2016; S.524 - Comprehensive Addiction and Recovery Act of 2016 - HCV testing provision in bill; S.1287 - Viral Hepatitis Testing Act of 2015. Prison population and hepatitis C.
Pending healthcare legislation and potential impact on the biopharmaceutical industry; Ryan White Care Act reauthorization; Hepatitis C policy; PEPFAR reauthorization; HIV/AIDS research, testing, and treatment; Affordable Care Act implementation; HCV screening and linkage to care programs; House Committee on Energy and Commerce 21st Century Cures initiative. Funding for HCV and public health activities via appropriations. Pharmaceutical policy as it relates to payments under the 340B program. S.1287 - Viral Hepatitis Testing Act of 2015. Prison population and hepatitis C.
Pending healthcare legislation and potential impact on the biopharmaceutical industry; Ryan White Care Act reauthorization; Hepatitis C policy; PEPFAR reauthorization; HIV/AIDS research, testing, and treatment; Affordable Care Act implementation; HCV screening and linkage to care programs; H.R. 6 - 21st Century Cures Act. Funding for HCV and public health activities via appropriations. Pharmaceutical policy as it relates to payments under the 340B program; implementation of section 340B drug discount program. S. 3056 - CREATES Act of 2016; S.524 - Comprehensive Addiction and Recovery Act of 2016 - HCV testing provision in bill; S.1287 - Viral Hepatitis Testing Act of 2015. Prison population and hepatitis C.The FOCUS program.
Pending healthcare legislation and potential impact on the biopharmaceutical industry; Ryan White Care Act reauthorization; Hepatitis C policy; PEPFAR reauthorization; HIV/AIDS research, testing, and treatment; Affordable Care Act implementation; HCV screening and linkage to care programs; House Committee on Energy and Commerce 21st Century Cures initiative. Funding for HCV and public health activities via appropriations. Pharmaceutical policy as it relates to payments under the 340B program; implementation of section 340B drug discount program. S. 3056 - CREATES Act of 2016; S.524 - Comprehensive Addiction and Recovery Act of 2016 - HCV testing provision in bill; S.1287 - Viral Hepatitis Testing Act of 2015. Prison population and hepatitis C.
Pending healthcare legislation and potential impact on the biopharmaceutical industry; Ryan White Care Act reauthorization; Hepatitis C policy; PEPFAR reauthorization; HIV/AIDS research, testing, and treatment; Affordable Care Act implementation; HCV screening and linkage to care programs; House Committee on Energy and Commerce 21st Century Cures initiative. Funding for HCV and public health activities via appropriations. Pharmaceutical policy as it relates to payments under the 340B program; implementation of section 340B drug discount program. S. 3056 - CREATES Act of 2016; S.524 - Comprehensive Addiction and Recovery Act of 2016 - HCV testing provision in bill; S.1287 - Viral Hepatitis Testing Act of 2015. Prison population and hepatitis C.
Pending healthcare legislation and potential impact on the biopharmaceutical industry; Ryan White Care Act reauthorization; Hepatitis C policy; PEPFAR reauthorization; HIV/AIDS research, testing, and treatment; Affordable Care Act implementation; HCV screening and linkage to care programs; House Committee on Energy and Commerce 21st Century Cures initiative. Funding for HCV and public health activities via appropriations. Pharmaceutical policy as it relates to payments under the 340B program; implementation of section 340B drug discount program. S. 3056 - CREATES Act of 2016; S.524 - Comprehensive Addiction and Recovery Act of 2016 - HCV testing provision in bill; S.1287 - Viral Hepatitis Testing Act of 2015. Prison population and hepatitis C.
Coverage of pharmaceuticals, cost-sharing and other access issues; 21st Century Cures initiative; Implementation of Public Law No: 111-148, the Patient Protection and Affordable Care Act; issues related to coverage and reimbursement of pharmaceuticals; issues related to Medicare, Medicaid and Affordable Care Act implementation; FDA issues and 340B. S. 3056: CREATES Act of 2016. Indian Health Services.
Coverage of pharmaceuticals, cost-sharing and other access issues; H.R. 6 - 21st Century Cures Act; Implementation of Public Law No: 111-148, the Patient Protection and Affordable Care Act; issues related to coverage and reimbursement of pharmaceuticals; issues related to Medicare, Medicaid, and Affordable Care Act implementation; FDA issues and 340B. S. 3056 - CREATES Act of 2016.
Pending healthcare legislation and potential impact on the biopharmaceutical industry; Ryan White Care Act reauthorization; Hepatitis C policy; PEPFAR reauthorization; HIV/AIDS research, testing, and treatment; Affordable Care Act implementation; HCV screening and linkage to care programs; H.R. 6 - 21st Century Cures Act. Funding for HCV and public health activities via appropriations. Pharmaceutical policy as it relates to payments under the 340B program; implementation of section 340B drug discount program. S. 3056 - CREATES Act of 2016; S.524 - Comprehensive Addiction and Recovery Act of 2016 - HCV testing provision in bill; S.1287 - Viral Hepatitis Testing Act of 2015. Prison population and hepatitis C.The FOCUS program.
Coverage of pharmaceuticals, cost-sharing and other access issues; 21st Century Cures initiative; Implementation of Public Law No: 111-148, the Patient Protection and Affordable Care Act; issues related to coverage and reimbursement of pharmaceuticals; issues related to Medicare, Medicaid and Affordable Care Act implementation; FDA issues and 340B. S. 3056: CREATES Act of 2016.
Comprehensive Addiction and Recovery Act of 2016
Client: GILEAD SCIENCES INC · Firm: GILEAD SCIENCES, INC.
Pending healthcare legislation and potential impact on the biopharmaceutical industry; Ryan White Care Act reauthorization; Hepatitis C policy; PEPFAR reauthorization; HIV/AIDS research, testing, and treatment; Affordable Care Act implementation; HCV screening and linkage to care programs; House Committee on Energy and Commerce 21st Century Cures initiative. Funding for HCV and public health activities via appropriations. Pharmaceutical policy as it relates to payments under the 340B program; implementation of section 340B drug discount program. S. 3056 - CREATES Act of 2016; S.524 - Comprehensive Addiction and Recovery Act of 2016 - HCV testing provision in bill; S.1287 - Viral Hepatitis Testing Act of 2015. Prison population and hepatitis C.
Comprehensive Addiction and Recovery Act of 2016
Client: GILEAD SCIENCES INC · Firm: GILEAD SCIENCES, INC.
Pending healthcare legislation and potential impact on the biopharmaceutical industry; Ryan White Care Act reauthorization; Hepatitis C policy; PEPFAR reauthorization; HIV/AIDS research, testing, and treatment; Affordable Care Act implementation; HCV screening and linkage to care programs; House Committee on Energy and Commerce 21st Century Cures initiative. Funding for HCV and public health activities via appropriations. Pharmaceutical policy as it relates to payments under the 340B program; implementation of section 340B drug discount program. S. 3056 - CREATES Act of 2016; S.524 - Comprehensive Addiction and Recovery Act of 2016 - HCV testing provision in bill; S.1287 - Viral Hepatitis Testing Act of 2015. Prison population and hepatitis C.
Comprehensive Addiction and Recovery Act of 2016
Client: GILEAD SCIENCES INC · Firm: GILEAD SCIENCES, INC.
Pending healthcare legislation and potential impact on the biopharmaceutical industry; Ryan White Care Act reauthorization; Hepatitis C policy; PEPFAR reauthorization; HIV/AIDS research, testing, and treatment; Affordable Care Act implementation; HCV screening and linkage to care programs; H.R. 6 - 21st Century Cures Act. Funding for HCV and public health activities via appropriations. Pharmaceutical policy as it relates to payments under the 340B program; implementation of section 340B drug discount program. S. 3056 - CREATES Act of 2016; S.524 - Comprehensive Addiction and Recovery Act of 2016 - HCV testing provision in bill; S.1287 - Viral Hepatitis Testing Act of 2015. Prison population and hepatitis C.The FOCUS program.
Veteran Access to Care Act of 2014
Client: GILEAD SCIENCES INC · Firm: GILEAD SCIENCES, INC.
Appropriations; Education related to Hepatitis C treatment guidelines (veterans) and funding issues (FY17 Appropriations bill). Issues related to coverage, access and reimbursement of pharmaceuticals for veterans. Education related to Implementation of Veterans Access to Care Act, HR 4810/3230 and PL 113-146. Health care for judiciary involved veterans.
Veteran Access to Care Act of 2014
Client: GILEAD SCIENCES INC · Firm: GILEAD SCIENCES, INC.
Appropriations; education related to Hepatitis C treatment guidelines and funding issues. Issues related to coverage, access and reimbursement of pharmaceuticals for veterans. Education related to Implementation of Veterans Access to Care Act, HR 4810/3230 and PL 113-146.
U.S.-Israel Security Cooperation Act
Client: GILEAD SCIENCES INC · Firm: GILEAD SCIENCES, INC.
Appropriations; education related to Hepatitis C. Access to Care Act, HR 4810. Issues related to coverage, access and reimbursement of pharmaceuticals for veterans.
U.S.-Israel Security Cooperation Act
Client: GILEAD SCIENCES INC · Firm: GILEAD SCIENCES, INC.
Education related to Hepatitis C. Access to Care Act, HR 4810
U.S.-Israel Security Cooperation Act
Client: GILEAD SCIENCES INC · Firm: GILEAD SCIENCES, INC.
Appropriations; education related to Hepatitis C. Access to Care Act, HR 4810. Issues related to coverage, access and reimbursement of pharmaceuticals for veterans.
HIV/AIDS testing and treatment, technology transfer and patent rights and funding, patent reform legislation. Patient Protection and Affordable Care Act implementation. Issues related to access to pharmaceuticals and intellectual property protection. Intellectual property reform. S.1137 - PATENT Act & HR. 9 - Innovation Act
HIV/AIDS testing and treatment, technology transfer and patent rights and funding, patent reform legislation. Patient Protection and Affordable Care Act implementation. Issues related to access to pharmaceuticals and intellectual property protection. Intellectual property reform. S.1137 - PATENT Act & HR. 9 - Innovation Act
Pending healthcare legislation and potential impact on the biopharmaceutical industry; Ryan White Care Act reauthorization; Hepatitis C policy; PEPFAR reauthorization; HIV/AIDS research, testing, and treatment; Affordable Care Act implementation; HCV screening and linkage to care programs; House Committee on Energy and Commerce 21st Century Cures initiative. Funding for HCV and public health activities via appropriations. Pharmaceutical policy as it relates to payments under the 340B program. S.1287 - Viral Hepatitis Testing Act of 2015.
Veteran Access to Care Act of 2014
Client: GILEAD SCIENCES INC · Firm: GILEAD SCIENCES, INC.
Appropriations; education related to Hepatitis C treatment guidelines and funding issues. Issues related to coverage, access and reimbursement of pharmaceuticals for veterans. Education related to Implementation of Veterans Access to Care Act, HR 4810/3230 and PL 113-146.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2014
Client: GILEAD SCIENCES INC · Firm: GILEAD SCIENCES, INC.
International Trade and protection of intellectual property; HIV Testing Issues, ADAP Funding Issues, HCV issues; Ryan White Care Act reauthorization, Hepatitis C Policy, PEPFAR reauthorization; Healthcare Legislation issues; Domestic HIV Policy issues, Hepatitis B Funding for Screening and Linkage to Care Programs, Budget Control Act of 2011 (P.L. 112-25); S.1284, FY2014 Labor, HHS and Education Appropriations; Implementation of Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148)Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152) Implementation of the American Tax payer Relief Act of 2012 (Pub. L. 112-240, H.R. 8) Implementation of Health Care Reform PL 111-148 HIV/AIDS testing and treatment, technology transfer and patent rights and funding.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2014
Client: GILEAD SCIENCES INC · Firm: GILEAD SCIENCES, INC.
International Trade and protection of intellectual property; HIV Testing Issues, HCV issues. Guidance and strategic counsel with regard to pending healthcare legislation and the potential impact on the biopharmaceutical industry; Ryan White Act reauthorization; Hepatitis C policy; PEPFAR reauthorization.Domestic HIV Policy Issues, Hepatitis B Funding for Screening and Linkage to Care Programs, Budget Control Act of 2011 (P.L. 112-25); S. 1284, FY 2014 Labor, HHS and Education Appropriations, Hepatitis Funding for Screening and Linkage to Care Programs.
HIV Prevention, Testing and Treatment; Technology Transfer and Patent Rights and Funding HIV/AIDS Funding, including ADAP Funding; Hepatitis C Policy; Hepatitis C issues; Hepatitis Funding for Screening and Linkage to Care Programs Ryan White Care Act Reauthorization; Federal Employees Health Benefits Program CoveragePEPFAR Reauthorization; Implementation of Patient Protection and Affordable Care Act; Hepatitis B Funding for Screening and Linkage to Care Programs; Budget Control Act of 2011 (P.L. 112-25); Health Care and Education Reconciliation Act of 2010 (Pub. l. 111-152); Implementation of the American Taxpayer Relief Act of 2012 Pub. L. 112-240, H.R. 8
International Trade and protection of intellectual property; HIV Testing Issues, ADAP Funding Issues, HCV issues; Ryan White Care Act reauthorization, Hepatitis C Policy, PEPFAR reauthorization; Healthcare Legislation issues; Domestic HIV Policy issues, Hepatitis B Funding for Screening and Linkage to Care Programs, Budget Control Act of 2011 (P.L. 112-25); S.1284, FY2014 Labor, HHS and Education Appropriations; Implementation of Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148)Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152) Implementation of the American Tax payer Relief Act of 2012 (Pub. L. 112-240, H.R. 8) Implementation of Health Care Reform PL 111-148 HIV/AIDS testing and treatment, technology transfer and patent rights and funding.
Education related to Hepatitis C
Issues related to healthcare funding and cost-savings.
Technology transfer, patent rights and funding, patent reform legislation. Patient Protection and Affordable Care Act implementation. Issues related to pharmaceuticals and intellectual property protection. Intellectual property reform.
Coverage of pharmaceuticals, cost-sharing and other access issues; Implementation of Public Law No: 111-148, the Patient Protection and Affordable Care Act; issues related to coverage and reimbursement of pharmaceuticals; issues related to Medicare, Medicaid, and Affordable Care Act implementation; FDA issues and 340B.
Issues related to pharmaceuticals, international finance for health services and intellectual property protection.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS), Veterans Affairs, Dept of (VA)
GILEAD SCIENCES INC via GILEAD SCIENCES, INC.
2016 · fourth_quarter · Q4
Ryan White Care Act reauthorization; Hepatitis C (HCV) policy; PEPFAR reauthorization; HIV/AIDS research, testing, and treatment; Affordable Care Act implementation; HCV testing, screening and linkage to care programs; H.R. 6 - 21st Century Cures Act. Federal program coverage; access and reimbursement issues for Hepatitis C, HIV, and oncology products. Coverage of pharmaceuticals, cost-sharing and other access issues; Implementation of Public Law No: 111-148; issues related to coverage and reimbursement of pharmaceuticals; FDA issues and 340B.
Coverage of pharmaceuticals, cost-sharing and other access issues; H.R. 6 - 21st Century Cures Act; Implementation of Public Law No: 111-148, the Patient Protection and Affordable Care Act; issues related to coverage and reimbursement of pharmaceuticals; issues related to Medicare, Medicaid, and Affordable Care Act implementation; FDA issues and 340B. S. 3056 - CREATES Act of 2016.
Issues related to healthcare funding and cost-savings.
Pending healthcare legislation and potential impact on the biopharmaceutical industry; Ryan White Care Act reauthorization; Hepatitis C policy; PEPFAR reauthorization; HIV/AIDS research, testing, and treatment; Affordable Care Act implementation; HCV screening and linkage to care programs; H.R. 6 - 21st Century Cures Act. Funding for HCV and public health activities via appropriations. Pharmaceutical policy as it relates to payments under the 340B program; implementation of section 340B drug discount program. S. 3056 - CREATES Act of 2016; S.524 - Comprehensive Addiction and Recovery Act of 2016 - HCV testing provision in bill; S.1287 - Viral Hepatitis Testing Act of 2015. Prison population and hepatitis C.The FOCUS program.
Appropriations; Education related to Hepatitis C treatment guidelines (veterans) and funding issues (FY17 Appropriations bill). Issues related to coverage, access and reimbursement of pharmaceuticals for veterans. Education related to Implementation of Veterans Access to Care Act, HR 4810/3230 and PL 113-146. Health care for judiciary involved veterans.
International trade and protection of intellectual property
Issues related to access to pharmaceuticals, international finance for health services and intellectual property protection.
Incarcerated population relating to Hepatitis C and health care.
HIV/AIDS testing and treatment, technology transfer and patent rights and funding, patent reform legislation. Patient Protection and Affordable Care Act implementation. Issues related to access to pharmaceuticals and intellectual property protection. Intellectual property reform. S.1137 - PATENT Act & HR. 9 - Innovation Act.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)
GILEAD SCIENCES INC via GILEAD SCIENCES, INC.
2016 · third_quarter · Q3
Coverage of pharmaceuticals, cost-sharing and other access issues; 21st Century Cures initiative; Implementation of Public Law No: 111-148, the Patient Protection and Affordable Care Act; issues related to coverage and reimbursement of pharmaceuticals; issues related to Medicare, Medicaid and Affordable Care Act implementation; FDA issues and 340B. S. 3056: CREATES Act of 2016. Indian Health Services.
Education related to HCV issues.
HIV/AIDS testing and treatment, technology transfer and patent rights and funding, patent reform legislation. Patient Protection and Affordable Care Act implementation. Issues related to access to pharmaceuticals and intellectual property protection. Intellectual property reform. S.1137 - PATENT Act & HR. 9 - Innovation Act.
Appropriations; education related to Hepatitis C treatment guidelines and funding issues (FY2016 Omnibus Appropriations bill.) Issues related to coverage, access and reimbursement of pharmaceuticals for veterans. Education related to Implementation of Veterans Access to Care Act, HR 4810/3230 and PL 113-146. Health care for judiciary involved veterans.
Incarcerated population relating to Hepatitis C and health care
International trade and protection of intellectual property; HIV testing issues; ADAP issues; Hepatitis C issues; patent reform
Ryan White Care Act reauthorization; Hepatitis C (HCV) policy; PEPFAR reauthorization; HIV/AIDS research, testing, and treatment; Affordable Care Act implementation; HCV testing, screening and linkage to care programs; House Committee on Energy and Commerce 21st Century Cures initiative. Federal program coverage; access and reimbursement issues for Hepatitis C, HIV, and oncology products. Coverage of pharmaceuticals, cost-sharing and other access issues; Implementation of Public Law No: 111-148; issues related to coverage and reimbursement of pharmaceuticals; FDA issues and 340B.
Issues related to healthcare funding and cost-savings.
Issues related to access to pharmaceuticals, international finance for health services and intellectual property protection.
Pending healthcare legislation and potential impact on the biopharmaceutical industry; Ryan White Care Act reauthorization; Hepatitis C policy; PEPFAR reauthorization; HIV/AIDS research, testing, and treatment; Affordable Care Act implementation; HCV screening and linkage to care programs; House Committee on Energy and Commerce 21st Century Cures initiative. Funding for HCV and public health activities via appropriations. Pharmaceutical policy as it relates to payments under the 340B program; implementation of section 340B drug discount program. S. 3056 - CREATES Act of 2016; S.524 - Comprehensive Addiction and Recovery Act of 2016 - HCV testing provision in bill; S.1287 - Viral Hepatitis Testing Act of 2015. Prison population and hepatitis C.
Filing targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Indian Health Service, Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), Veterans Affairs, Dept of (VA)
GILEAD SCIENCES INC via GILEAD SCIENCES, INC.
2016 · second_quarter · Q2
Issues related to access to pharmaceuticals, international finance for health services and intellectual property protection.
Pending healthcare legislation and potential impact on the biopharmaceutical industry; Ryan White Care Act reauthorization; Hepatitis C policy; PEPFAR reauthorization; HIV/AIDS research, testing, and treatment; Affordable Care Act implementation; HCV screening and linkage to care programs; House Committee on Energy and Commerce 21st Century Cures initiative. Funding for HCV and public health activities via appropriations. Pharmaceutical policy as it relates to payments under the 340B program; implementation of section 340B drug discount program. S. 3056 - CREATES Act of 2016; S.524 - Comprehensive Addiction and Recovery Act of 2016 - HCV testing provision in bill; S.1287 - Viral Hepatitis Testing Act of 2015. Prison population and hepatitis C.
Ryan White Care Act reauthorization; Hepatitis C (HCV) policy; PEPFAR reauthorization; HIV/AIDS research, testing, and treatment; Affordable Care Act implementation; HCV testing, screening and linkage to care programs; House Committee on Energy and Commerce 21st Century Cures initiative. Federal program coverage; access and reimbursement issues for Hepatitis C, HIV, and oncology products. Coverage of pharmaceuticals, cost-sharing and other access issues; Implementation of Public Law No: 111-148; issues related to coverage and reimbursement of pharmaceuticals; FDA issues and 340B.
Appropriations; education related to Hepatitis C treatment guidelines and funding issues (FY2016 Omnibus Appropriations bill.) Issues related to coverage, access and reimbursement of pharmaceuticals for veterans. Education related to Implementation of Veterans Access to Care Act, HR 4810/3230 and PL 113-146.
HIV/AIDS testing and treatment, technology transfer and patent rights and funding, patent reform legislation. Patient Protection and Affordable Care Act implementation. Issues related to access to pharmaceuticals and intellectual property protection. Intellectual property reform. S.1137 - PATENT Act & HR. 9 - Innovation Act.
Issues related to healthcare funding and cost-savings.
International trade and protection of intellectual property; HIV testing issues; ADAP issues; Hepatitis C issues; patent reform
Education related to HCV issues.
Coverage of pharmaceuticals, cost-sharing and other access issues; 21st Century Cures initiative; Implementation of Public Law No: 111-148, the Patient Protection and Affordable Care Act; issues related to coverage and reimbursement of pharmaceuticals; issues related to Medicare, Medicaid and Affordable Care Act implementation; FDA issues and 340B. S. 3056: CREATES Act of 2016.
Filing targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), Veterans Affairs, Dept of (VA)
GILEAD SCIENCES INC via GILEAD SCIENCES, INC.
2016 · first_quarter · Q1
International trade and protection of intellectual property; HIV testing issues; ADAP issues; Hepatitis C issues; patent reform
HIV/AIDS testing and treatment, technology transfer and patent rights and funding, patent reform legislation. Patient Protection and Affordable Care Act implementation. Issues related to access to pharmaceuticals and intellectual property protection. Intellectual property reform. S.1137 - PATENT Act & HR. 9 - Innovation Act
Appropriations; education related to Hepatitis C treatment guidelines and funding issues. Issues related to coverage, access and reimbursement of pharmaceuticals for veterans. Education related to Implementation of Veterans Access to Care Act, HR 4810/3230 and PL 113-146.
Coverage of pharmaceuticals, cost-sharing and other access issues; 21st Century Cures initiative; Implementation of Public Law No: 111-148, the Patient Protection and Affordable Care Act; Issues related to coverage and reimbursement of pharmaceuticals; Issues related to Medicare, Medicaid and Affordable Care Act implementation; and FDA issues and 340B.
Ryan White Care Act reauthorization; Hepatitis C (HCV) policy; PEPFAR reauthorization; HIV/AIDS research, testing, and treatment; Affordable Care Act implementation; HCV testing, screening and linkage to care programs; House Committee on Energy and Commerce 21st Century Cures initiative. Federal program coverage; access and reimbursement issues for Hepatitis C, HIV, and oncology products. Coverage of pharmaceuticals, cost-sharing and other access issues; Implementation of Public Law No: 111-148; issues related to coverage and reimbursement of pharmaceuticals; FDA issues and 340B.
Pending healthcare legislation and potential impact on the biopharmaceutical industry; Ryan White Care Act reauthorization; Hepatitis C policy; PEPFAR reauthorization; HIV/AIDS research, testing, and treatment; Affordable Care Act implementation; HCV screening and linkage to care programs; House Committee on Energy and Commerce 21st Century Cures initiative. Funding for HCV and public health activities via appropriations. Pharmaceutical policy as it relates to payments under the 340B program. S.1287 - Viral Hepatitis Testing Act of 2015. Prison population and hepatitis C.
Education related to HCV issues.
Filing targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), Veterans Affairs, Dept of (VA)
GILEAD SCIENCES INC via GILEAD SCIENCES, INC.
2015 · fourth_quarter · Q4
HIV/AIDS testing and treatment, technology transfer and patent rights and funding, patent reform legislation. Patient Protection and Affordable Care Act implementation. Issues related to access to pharmaceuticals and intellectual property protection. Intellectual property reform. S.1137 - PATENT Act & HR. 9 - Innovation Act
Appropriations; education related to Hepatitis C treatment guidelines and funding issues. Issues related to coverage, access and reimbursement of pharmaceuticals for veterans. Education related to Implementation of Veterans Access to Care Act, HR 4810/3230 and PL 113-146.
GILEAD SCIENCES INC via GILEAD SCIENCES, INC.
2015 · third_quarter · Q3
International trade and protection of intellectual property; HIV policy issues, HCV issues, patent reform
Appropriations; education related to Hepatitis C. Access to Care Act, HR 4810. Issues related to coverage, access and reimbursement of pharmaceuticals for veterans.
Education related to HCV issues.
GILEAD SCIENCES INC via GILEAD SCIENCES, INC.
2015 · second_quarter · Q2
International Trade and protection of intellectual property; HIV policy Issues, HCV issues, Patent Reform.
Pending healthcare legislation and potential impact on the biopharmaceutical industry; Ryan White Care Act reauthorization; Hepatitis C policy; PEPFAR reauthorization, Ryan White Care Act reauthorization; Hepatitis C (HCV) policy; PEPFAR reauthorization; HIV/AIDS research, testing, and treatment; Affordable Care Act implementation; HCV screening and linkage to care programs; House Committee on Energy and Commerce 21st Century Cures initiative. HIV/AIDS testing and treatment, technology transfer and patent rights, and funding. Patient Protection and Affordable Care Act implementation. Hepatitis funding for screening and linkage to care programs.
GILEAD SCIENCES INC via GILEAD SCIENCES, INC.
2015 · first_quarter · Q1
Education related to HCV issues.
HIV/AIDS testing and treatment, technology transfer and patent rights and funding. Patient Protection and Affordable Care Act implementation.
Pending healthcare legislation and potential impact on the biopharmaceutical industry; Ryan White Care Act reauthorization; Hepatitis C policy; PEPFAR reauthorization, Ryan White Care Act reauthorization; Hepatitis C (HCV) policy; PEPFAR reauthorization; HIV/AIDS research, testing, and treatment; Affordable Care Act implementation; HCV screening and linkage to care programs; House Committee on Energy and Commerce 21st Century Cures initiative. HIV/AIDS testing and treatment, technology transfer and patent rights, and funding. Patient Protection and Affordable Care Act implementation. Hepatitis funding for screening and linkage to care programs.
GILEAD SCIENCES INC via GILEAD SCIENCES, INC.
2014 · fourth_quarter · Q4
Education related to HCV issues.
Medicare and Medicaid coverage, access and reimbursement issues for HCV and HIV products; Affordable Care Act (Pub. Laws 111-148 and -152)implementation. Federal program coverage, access and reimbursement issues for Hepatitis C and HIV products. HIV/AIDS testing and treatment, technology transfer and patent rights, and funding.
Ryan White Care Act reauthorization; Hepatitis C policy; PEPFAR reauthorization. HIV/AIDS research, testing and treatment; Affordable Care Act implementation; HCV screening and linkage to care programs; House Committee on Energy & Commerce 21st Century Cures initiative, Technology transfer and patent rights, and funding and coverage and reimbursement policy for HCV portfolio
GILEAD SCIENCES INC via GILEAD SCIENCES, INC.
2014 · third_quarter · Q3
International trade and protection of intellectual property; HIV policy issues, HCV issues.
Education related to Hepatitis C issues.
Provide guidance and strategic counsel with regard to pending healthcare legislation and the potential impact on the biopharmaceutical industry; Ryan White Care Act reauthorization; Hepatitis C policy; PEPFAR reauthorization. HIV/AIDS testing and treatment, technology transfer and patent rights, and funding. Patient Protection and Affordable Care Act implementation. Hepatitis funding for screening and linkage to care programs. Coverage and reimbursement policy for HCV.
GILEAD SCIENCES INC via GILEAD SCIENCES, INC.
2014 · second_quarter · Q2
Provide guidance and strategic counsel with regard to pending healthcare legislation and the potential impact on the biopharmaceutical industry; Ryan White Care Act reauthorization; Hepatitis C policy; PEPFAR reauthorization.HIV/AIDS testing and treatment, technology transfer and patent rights, and funding. Patient Protection and Affordable Care Act implementation. Hepatitis funding for screening and linkage to care programs. Issues related to Hepatitis C.
International Trade and protection of intellectual property; HIV policy Issues, HCV issues.
Medicare and Medicaid coverage, access and reimbursement issues for Hepatitis C and HIV products.HIV/AIDS testing and treatment, technology transfer and patent rights, and funding. Patient Protection and Affordable Care Act implementation. Hepatitis funding for screening and linkage to care programs.
GILEAD SCIENCES INC via GILEAD SCIENCES, INC.
2014 · first_quarter · Q1
HIV/AIDS testing and treatment, technology transfer and patent rights and funding Patient Protection and Affordable Care Act implementation.
Education regarding Hepatitis C
HIV/AIDS testing and treatment, technology transfer and patent rights, and funding. Patient Protection and Affordable Care Act implementation. Hepatitis funding for screening and linkage to care programs.
GILEAD SCIENCES INC via GILEAD SCIENCES, INC.
2013 · fourth_quarter · Q4
International Trade and protection of intellectual property; HIV Testing Issues, HCV issues. Guidance and strategic counsel with regard to pending healthcare legislation and the potential impact on the biopharmaceutical industry; Ryan White Act reauthorization; Hepatitis C policy; PEPFAR reauthorization.Domestic HIV Policy Issues, Hepatitis B Funding for Screening and Linkage to Care Programs, Budget Control Act of 2011 (P.L. 112-25); S. 1284, FY 2014 Labor, HHS and Education Appropriations, Hepatitis Funding for Screening and Linkage to Care Programs.
HIV/AIDS testing and treatment, technology transfer and patent rights and funding Patient Protection and Affordable Care Act implementation.
GILEAD SCIENCES INC via GILEAD SCIENCES, INC.
2013 · third_quarter · Q3
HIV/AIDS testing and treatment, technology transfer and patent rights and funding; Patient Protection and Affordable Care Act Implementation; Hepatitis Funding for Screening and Linkage to Care Programs; Medicare and Medicaid Coverage, Access and Reimbursement Issues.
Education regarding Hepatitis C Issues.
HIV/AIDS testing and treatment, technology transfer and patent rights and funding. Patient Protection and Affordable Care Act Implementation.
GILEAD SCIENCES INC via GILEAD SCIENCES, INC.
2013 · first_quarter · 1A
HIV/AIDS Technology Transfer and Patent Rights
HIV Prevention, Testing and Treatment; HIV/AIDS Funding , including ADAP Funding; Hepatitis B and C Policy; Ryan White Care Act reauthorization
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS)
GILEAD SCIENCES INC via GILEAD SCIENCES, INC.
2013 · second_quarter · Q2
HIV/ AIDS Testing and Treatment, Technology Transfer and Patent Rights and Funding; Patient Protection and Affordable Care Act Implementation; Hepatitis Funding for Screening and Linkage to Care Programs
HIV Prevention, Testing and Treatment; Technology Transfer and Patent Rights and Funding HIV/AIDS Funding, including ADAP Funding; Hepatitis C Policy; Hepatitis C issues; Hepatitis Funding for Screening and Linkage to Care Programs Ryan White Care Act Reauthorization; Federal Employees Health Benefits Program CoveragePEPFAR Reauthorization; Implementation of Patient Protection and Affordable Care Act; Hepatitis B Funding for Screening and Linkage to Care Programs; Budget Control Act of 2011 (P.L. 112-25); Health Care and Education Reconciliation Act of 2010 (Pub. l. 111-152); Implementation of the American Taxpayer Relief Act of 2012 Pub. L. 112-240, H.R. 8
GILEAD SCIENCES INC via GILEAD SCIENCES, INC.
2013 · first_quarter · Q1
HIV/AIDS technology transfer and patent rights
HIV prevention, testing and treatment; HIV/AIDS funding, including ADAP funding; Hepatitis B and C policy; Ryan White Care Act reauthorization;PEPFAR reauthorization; Implementation of Patient Protection and Affordable Care Act (P.L. 111-148)
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS)
GILEAD SCIENCES INC via GILEAD SCIENCES, INC.
2012 · fourth_quarter · Q4
HIV/AIDS Testing and Treatment; HIV/AIDS technology transfer and patent rights; HIV/AIDS Funding; Patient Protection and Affordable Care Act implementation
HIV/AIDS Testing and treatment; HIV/AIDS technology transfer and patent rights; HIV/AIDS funding; Patient Protection and Affordable Care Act Implementation; Hepatitis funding for screening and linkage to care programs
HIV Prevention; HIV Treatment and Testing; Intellectual Property Rights; Domestic HIV Policy Issues; Hepatitis B Funding for Screening and Linkage to Care Programs; Budget Control Act of 2011(P.L. 112-25); Ryan White Care Act Reauthorization; Hepatitis C Issues; HIV/AIDS testing and treatment; HIV/AIDS technology transfer and patent rights; HIV/AIDS Funding; Patient Protection and Affordable Care Act implementation; Federal Employes Health Benefits Program coverage; Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152)
GILEAD SCIENCES INC via GILEAD SCIENCES, INC.
2012 · third_quarter · Q3
Domestic HIV Policy issues: HIV Prevention; HIV Testing and Treatment; Federal Employees Health Benefits and Program Coverage for Routine HIV screening; HIV/AIDS Funding; Ryan White Program. Health Care Reform (Implementation of Patient Protection and Affordable Care Act - P.L.111-148; Health Care and Education Affordability Reconciliation Act - P.L.111-152); Hepatitis Funding for Screening and Linkage to Care Programs; International HIV and Health issues; HIV/AIDS Technology Transfer and Patent Rights; International Trade and Intellectual Property Rights issues.
Filing targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA), White House Office
GILEAD SCIENCES INC via GILEAD SCIENCES, INC.
2012 · second_quarter · Q2
Domestic HIV Policy issues: HIV Prevention; HIV Testing and Treatment; Federal Employees Health Benefits and Program Coverage for Routine HIV screening; HIV/AIDS Funding; Ryan White Program. Health Care Reform ( Patient Protection and Affordable Care Act - P.L.111-148; Health Care and Education Affordability Reconciliation Act - P.L.111-152); Hepatitis B Funding for Screening and Linkage to Care Programs; Hepatitis C Policy; Medicare Part D and Dual Eligibles; International HIV and Health issues; PEPFAR; HIV/AIDS Technology Transfer and Patent Rights; International Trade and Intellectual Property Rights issues.
Filing targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA), White House Office
GILEAD SCIENCES INC via GILEAD SCIENCES, INC.
2012 · first_quarter · Q1
Domestic HIV Policy issues: HIV/AIDS Technology Transfer and Patent Rights; HIV Testing and Treatment; Federal Employees Health Benefits and Program Coverage for Routine HIV screening; HIV/AIDS Funding. Health Care Reform ( Patient Protection and Affordable Care Act - P.L.111-148; Health Care and Education Affordability Reconciliation Act - P.L.111-152); Hepatitis B Funding for Screening and Linkage to Care Programs; Hepatitis C Policy; Medicare Part D and Dual Eligibles; International HIV and Health issues; PEPFAR; International Trade and Intellectual Property Rights issues.
Filing targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA), White House Office
GILEAD SCIENCES INC via GILEAD SCIENCES, INC.
2011 · fourth_quarter · Q4
Domestic HIV Policy issues: HIV/AIDS Technology Transfer and Patent Rights; HIV Testing and Treatment; Federal Employees Health Benefits and Program Coverage for Routine HIV screening; HIV/AIDS Funding. Health Care Reform ( Patient Protection and Affordable Care Act - P.L.111-148; Health Care and Education Affordability Reconciliation Act - P.L.111-152); Hepatitis B Funding for Screening and Linkage to Care Programs; Medicare Part D and Dual Eligibles; International HIV and Health issues; International Trade and Intellectual Property Rights issues.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)
Education related to HCV issues.
Coverage of pharmaceuticals, cost-sharing and other access issues; 21st Century Cures initiative; Implementation of Public Law No: 111-148, the Patient Protection and Affordable Care Act; Issues related to coverage and reimbursement of pharmaceuticals; Issues related to Medicare, Medicaid and Affordable Care Act implementation; and FDA issues and 340B.
Pending healthcare legislation and potential impact on the biopharmaceutical industry; Ryan White Care Act reauthorization; Hepatitis C policy; PEPFAR reauthorization; HIV/AIDS research, testing, and treatment; Affordable Care Act implementation; HCV screening and linkage to care programs; House Committee on Energy and Commerce 21st Century Cures initiative. Funding for HCV and public health activities via appropriations. Pharmaceutical policy as it relates to payments under the 340B program. S.1287 - Viral Hepatitis Testing Act of 2015.
Ryan White Care Act reauthorization; Hepatitis C (HCV) policy; PEPFAR reauthorization; HIV/AIDS research, testing, and treatment; Affordable Care Act implementation; HCV testing, screening and linkage to care programs; House Committee on Energy and Commerce 21st Century Cures initiative. Federal program coverage; access and reimbursement issues for Hepatitis C, HIV, and oncology products. Coverage of pharmaceuticals, cost-sharing and other access issues; Implementation of Public Law No: 111-148; issues related to coverage and reimbursement of pharmaceuticals; FDA issues and 340B.
International trade and protection of intellectual property; HIV testing issues; ADAP issues; Hepatitis C issues; patent reform
Filing targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), Veterans Affairs, Dept of (VA)
Specific lobbying issues: HIV/AIDS testing and treatment, technology transfer and patent rights and funding, patent reform legislation. Patient Protection and Affordable Care Act implementation.Issues related to access to pharmaceuticals and intellectual property protection.
Coverage of pharmaceuticals, cost-sharing and other access issues; 21st Century Cures initiative; Implementation of Public Law No: 111-148, the Patient Protection and Affordable Care Act; Issues related to coverage and reimbursement of pharmaceuticals; Issues related to Medicare, Medicaid and Affordable Care Act implementation; and FDA issues and 340B.
Ryan White Care Act reauthorization; Hepatitis C (HCV) policy; PEPFAR reauthorization; HIV/AIDS research, testing, and treatment; Affordable Care Act implementation; HCV screening and linkage to care programs; House Committee on Energy and Commerce 21st Century Cures initiative. Federal program coverage; access and reimbursement issues for Hepatitis C, HIV, and oncology products. Viral Hepatitis Testing, Screening and treatment;HIV Testing, Research and Treatment; Coverage of pharmaceuticals, cost-sharing and other access issues; 21st Century Cures initiative; Implementation of Public Law No: 111-148, the Patient Protection and Affordable Care Act;Issues related to coverage and reimbursement of pharmaceuticals; and FDA issues and 340B.
Pending healthcare legislation and potential impact on the biopharmaceutical industry; Ryan White Care Act reauthorization; Hepatitis C policy; PEPFAR reauthorization, Ryan White Care Act reauthorization; Hepatitis C (HCV) policy; PEPFAR reauthorization; HIV/AIDS research, testing, and treatment; Affordable Care Act implementation; HCV screening and linkage to care programs; House Committee on Energy and Commerce 21st Century Cures initiative. HIV/AIDS testing and treatment, technology transfer and patent rights, and funding. Patient Protection and Affordable Care Act implementation. Hepatitis funding for screening and linkage to care programs.
Filing targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), Veterans Affairs, Dept of (VA)
Appropriations; education related to Hepatitis C. Access to Care Act, HR 4810. Issues related to coverage, access and reimbursement of pharmaceuticals for veterans.
Education related to HCV issues.
Specific lobbying issues: HIV/AIDS testing and treatment, technology transfer and patent rights and funding, patent reform legislation. Patient Protection and Affordable Care Act implementation.Issues related to access to pharmaceuticals and intellectual property protection.
Ryan White Care Act reauthorization; Hepatitis C (HCV) policy; PEPFAR reauthorization; HIV/AIDS research, testing, and treatment; Affordable Care Act implementation; HCV screening and linkage to care programs; House Committee on Energy and Commerce 21st Century Cures initiative. Federal program coverage; access and reimbursement issues for Hepatitis C, HIV, and oncology products. Viral Hepatitis Testing, Screening and treatment;HIV Testing, Research and Treatment; Coverage of pharmaceuticals, cost-sharing and other access issues; 21st Century Cures initiative; Implementation of Public Law No: 111-148, the Patient Protection and Affordable Care Act;Issues related to coverage and reimbursement of pharmaceuticals; and FDA issues and 340B.
Filing targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS), Veterans Affairs, Dept of (VA)
Education related to Hepatitis C. Access to Care Act, HR 4810
Ryan White Care Act reauthorization; Hepatitis C (HCV) policy; PEPFAR reauthorization; HIV/AIDS research, testing, and treatment; Affordable Care Act implementation; HCV screening and linkage to care programs; House Committee on Energy and Commerce 21st Century Cures initiative. Federal program coverage; access and reimbursement issues for Hepatitis C, HIV, and oncology products.
International Trade and protection of intellectual property; HIV policy Issues, HCV issues, Patent Reform.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
International Trade and protection of intellectual property; HIV policy Issues, HCV issues
HIV/AIDS testing and treatment, technology transfer and patent rights, and funding. Patient Protection and Affordable Care Act implementation.
Education related to HCV issues.
Filing targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HIV/AIDS testing and treatment, technology transfer and patent rights, and funding. Patient Protection and Affordable Care Act implementation.
Medicare and Medicaid coverage, access and reimbursement issues for Hepatitis C and HIV products. HIV/AIDS testing and treatment, technology transfer and patent rights, and funding. Patient Protection and Affordable Care Act implementation. Hepatitis funding for screening and linkage to care programs.
Filing targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HIV/AIDS testing and treatment, technology transfer and patent rights, and funding. Patient Protection and Affordable Care Act implementation.
Filing targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Implementation of Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152).
International Trade and protection of intellectual property; HIV policy issues and HCV issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS), Veterans Affairs, Dept of (VA)
Education on hepatitis C issues.
Medicare and Medicaid coverage, access and reimbursement issues for Hepatitis C and HIV.
Filing targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
International Trade and protection of intellectual property; HIV Testing Issues, ADAP Funding Issues, HCV issues; Ryan White Care Act reauthorization, Hepatitis C Policy, PEPFAR reauthorization; Healthcare Legislation issues; Domestic HIV Policy issues, Hepatitis B Funding for Screening and Linkage to Care Programs, Budget Control Act of 2011 (P.L. 112-25); S.1284, FY2014 Labor, HHS and Education Appropriations; Implementation of Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148)Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152) Implementation of the American Tax payer Relief Act of 2012 (Pub. L. 112-240, H.R. 8) Implementation of Health Care Reform PL 111-148 HIV/AIDS testing and treatment, technology transfer and patent rights and funding.
Filing targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
HIV/AIDS Technology Transfer and Patent Rights and Funding Patient Protection and Affordable Care Act Implementation HIV/AIDS Testing and Treatment
International Trade and Protection of Intellectual Property; HIV/AIDS Testing Issues; ADAP Funding Issues
Filing targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS), Veterans Affairs, Dept of (VA)
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)